The most frequently used predictors were MVI, AFP, tumor size, tumor number, and HBV-DNA.<h4>Conclusion</h4>Existing recurrence prediction models for HBV-HCC demonstrate moderate predictive accuracy but are universally affected by a high risk of bias. The gene discussed is AFP; the disease is hepatocellular carcinoma.